Copyright
©The Author(s) 2023.
World J Clin Cases. Feb 6, 2023; 11(4): 725-737
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.725
Published online Feb 6, 2023. doi: 10.12998/wjcc.v11.i4.725
Table 1 Clinical features of the patients with portal vein aneurysm, regards the conservative treatment
Year | Ref. | Gender | Age | Etiology | Location | Morphology/size | Symptomatology | Complications | Comorbidity | Imaging | Treatment | Follow-up |
2015 | Prabhakar et al[48] | Male | 47 | None | Intrahepatic, left br | 18 mm | Shunt | CT | Surveillance | Alive | ||
2015 | Srikanth et al[49] | Female | 12 | Congenital | Right branch | Saccular | US, CT | Surveillance | ||||
2015 | Starikov et al[50] | Male | 27 | None | SMV aneurysm | 86 mm | Abdominal pain | Thrombosis CTPV | Acute pancreatitis | CT, MRI | Anticoagulation | 24 mo |
2016 | Gaba et al[3] | Female | 61 | None | Confluence | 50 mm | Ca colon; surgery | US, CT | Surveillance | |||
2016 | Hanafiah et al[12] | Male | 70 | Acquired | Right branch | Fusiform, 22 mm | HBV; cirrhosis, HCC | US, CT | No treatment | Died | ||
2016 | Nayman et al[51] | Female | 48 | Congenital | Intrahepatic, two br | Right 43, left 13 mm | Abdominal pain | US, CT | Surveillance | |||
2016 | Kurtcehajic et al[22] | Female | 75 | Congenital | Bifurcation | Saccular | Jundice | Biliopathy | US, CT, MRI | Usodeoxolic acid | Alive | |
2016 | Khairallah et al[13] | Female | 68 | Acquired | Bifurcation | Fusiform, 40 mm | Bleeding | Cirrhosis; portal Hyp | US, CT | No treatment | ||
2017 | Jaiswal et al[52] | Female | 59 | Congenital | Confluence | 53.7 mm | Abdominal pain | Cholelithias | US, CT | Surveillance | 18 mo | |
2017 | Guilbaud et al[53] | Male | 88 | Congenital | Main trunk | Saccular, 59 mm | Cholecystectomy | CT | Surveillance | |||
2018 | Maia et al[54] | Female | 67 | Congenital | Main trunk | 35 mm | Abdominal pain | Diabetes, arterial Hyp | US, CT | Surveillance | 12 mo | |
2018 | Ashmore et al[55] | Female | 62 | None | Confluence | Abdominal pain | CT | Surveillance | ||||
2018 | Martínez et al[56] | Female | 29 | Congenital | Left branch | Saccular, 28 mm | US, CT | Surveillance | ||||
2018 | Hirji et al[57] | Male | 62 | Congenital | Confluence | 50 mm | Diabetes, Parkinson | CT | Surveillance | 6 mo | ||
2018 | Alur et al[58] | Female | 45 | Congenital | Left branch | 21.5 mm | US, MRI | Surveillance | ||||
2018 | Chaubard et al[59] | Male | 66 | Congenital | Confluence | Saccular, 40 mm | Abdominal pain | T-cell hemopathy | US, CT | Surveillance | ||
2019 | Ramamoorthy et al[60] | Female | 42 | Congenital | Confluence | Fusiform, 26 mm | Abdominal pain | US, MRI | Surveillance | Alive | ||
2019 | De Vloo et al[4] | Male | 67 | None | Confluence | Fusiform, 55 mm | Abdominal pain | Thrombosis CTPV | Neuroendocrine tm | US, CT | Anticoagulation | |
2020 | Kabir et al[61] | Male | 77 | Congenital | Intrahepatic, left br | 28 mm | Abdominal pain | Abd. aortic aneurysm | US, MRI | Surveillance | 3 mo | |
2020 | Rana et al[29] | Female | 51 | Congenital | Confluence | 38 mm | Abdominal pain | US, EUS, CT | Surveillance | 30 mo | ||
2020 | Shams et al[62] | Male | 67 | None | SMV aneurysm | Abdominal pain | Thrombosis | Anticoagulation | 12 mo | |||
2020 | Watanabe et al[5] | Female | 69 | Congenital | Right branch | 35 mm | Thrombosis | US, CT | Surveillance | 120 mo | ||
2020 | Schilardi et al[6] | Male | 86 | Congenital | Right branch | 55 mm | Heart failure; COPD | US, CT | Surveillance | 24 mo | ||
2021 | Hernando et al[63] | Female | 51 | Congenital | Right branch | 25 mm | Abd. pain, jundice | Choledocholithiasis | US, MRI | Surveillance | ||
2021 | Priadko et al[32] | Male | 81 | Acquired | 48 mm | HBV, cirrhosis | US | Surveillance | 36 mo | |||
Female | 52 | None | Saccular, 42.3 mm | US, CT, MRI | Surveillance | 60 mo | ||||||
Male | 73 | None | Intrahepatic, right br | 27 mm | US | Surveillance | 12 mo | |||||
2021 | Tan et al[64] | Male | Congenital | Main trunk | 26 mm | CT | Surveillance | Alive | ||||
2021 | López et al[65] | Female | 41 | None | SMV aneurysm | 43 mm | Abdominal pain | Splenorenal shunt | CT | Surveillance | ||
2022 | Tri et al[31] | Male | 10 | Congenital | Main trunk | 36 mm | Abdominal pain | Thrombosis | CT | Anticoagulation | 6 mo | |
2022 | Villani et al[66] | Male | 73 | Acquired | Main trunk | Saccular, 40 mm | Cirrhosis, ascites | US, CT | Surveillance | |||
2022 | Mortazavi et al[67] | Male | 49 | Congenital | Main trunk | 21 mm | Abdominal pain | Cholelithias | CT | Surveillance | ||
2022 | Mohamadnejad et al[30] | Female | 76 | None | Intrahepatic, left br | 25 mm | Aneurysm, shunt | CT, EUS | Surveillance | |||
2022 | Kanamalla et al[7] | Male | 95 | Congenital | Confluence | Saccular, 35 mm | Thrombosis of ICV | Diabetes, arterial Hyp | CT | Anticoagulation |
- Citation: Kurtcehajic A, Zerem E, Alibegovic E, Kunosic S, Hujdurovic A, Fejzic JA. Portal vein aneurysm-etiology, multimodal imaging and current management. World J Clin Cases 2023; 11(4): 725-737
- URL: https://www.wjgnet.com/2307-8960/full/v11/i4/725.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i4.725